综合综合综合综合综合网_久久久精品国产亚洲一区二区三区_天天干夜操_国产v亚洲v天堂宗合_欧洲精品aaa一区二区

技術(shù)文章您現(xiàn)在的位置:首頁 > 技術(shù)文章 > 人CXC趨化因子配體2(CXCL2)ELISA試劑盒引用文獻(xiàn)

人CXC趨化因子配體2(CXCL2)ELISA試劑盒引用文獻(xiàn)

更新時間:2022-01-04   點擊次數(shù):936次

恒遠(yuǎn)產(chǎn)品文獻(xiàn):人CXC趨化因子配體2(CXCL2)ELISA試劑盒引用文獻(xiàn)

【文獻(xiàn)標(biāo)題】CXCL2-mediated ATR/CHK1 signaling pathway and?platinum resistance in?epithelial ovarian cancer

【作者】Sipei Nie, Yicong Wan, Hui Wang,et.al

【作者單位】南京醫(yī)科大學(xué)(Nanjing Medical University)

【文獻(xiàn)中引用產(chǎn)品】

人CXC趨化因子配體2(CXCL2)ELISA試劑盒

【關(guān)鍵詞】Epithelial ovarian cancer (EOC), Platinum-resistance, Chemokine, CXCL2

【DOI】doi.org/10.1186/s13048-021-00864-3

出版期刊】《RESEARCH》

【產(chǎn)品原文引用】

Enzyme?linked immunosorbent assay (ELISA)

Serum samples of platinum-resistant and platinum-sensitive patients and cell culture supernatants were respectively extracted for cytokine analysis. Human CXCL2 ELISA kits were purchased from Hengyuan? Biological Co. Ltd (Shanghai, China), and ELISA assay was performed as the manufacturers’ instructions. Each sample was duplicated.


聯(lián)